Sabrina Champsi
Toronto, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
One Week Exposure to a Somatostatin Receptor 2 Antagonist (SSTR2a) Enhances Glucagon Counterregulation to Insulin-Induced Hypoglycaemia and Does Not Worsen Glycemia in a Male Rat Model of Insulin-Requiring Type 2 Diabetes.
Journal: Diabetes, obesity & metabolism
Published: January 12, 2026
The epigenetic landscape of skeletal muscle in response to exercise and aging.
Journal: The FEBS journal
Published: November 12, 2025
Mitochondrial Biogenesis in Skeletal Muscle.
Journal: Advances in experimental medicine and biology
Published: August 29, 2025
Role of Prohibitins as Guardians of mitochondrial homeostasis.
Journal: Mitochondrion
Published: March 04, 2025
Focus on the Forgotten Organelle: Regulation of Lysosomes in Skeletal Muscle.
Journal: Exercise and sport sciences reviews
Published: January 17, 2025
Sulforaphane treatment mimics contractile activity-induced mitochondrial adaptations in muscle myotubes.
Journal: American journal of physiology. Cell physiology
Published: December 13, 2024
Regulation of lysosomes in skeletal muscle during exercise, disuse and aging.
Journal: Free radical biology & medicine
Published: June 03, 2024
Sulforaphane, Urolithin A, and ZLN005 induce time-dependent alterations in antioxidant capacity, mitophagy, and mitochondrial biogenesis in muscle cells.
Journal: Sports medicine and health science
Published: January 04, 2024
Evaluating the effectiveness of a novel somatostatin receptor 2 antagonist, ZT-01, for hypoglycemia prevention in a rodent model of type 2 diabetes.
Journal: Frontiers in pharmacology
Published: September 25, 2023
Showing 1-9 of 9
Last Updated: 09/26/2026